Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1074 of 6351
-
New diabetes may be early warning for pancreatic cancer – study aims to find hidden cases
Knowledge-focused Recruiting nowThe main goal of this study is to explore the relationship between new-onset diabetes mellitus/deteriorating diabetes and a subsequent diagnosis of pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early …
Sponsor: Nuvance Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Promising combo for tough leukemias hits snag: trial ends early
Disease control Stopped earlyThis phase II trial studies how well venetoclax and decitabine work in treating participants with acute myeloid leukemia that has come back or does not respond to treatment, or with high-risk myelodysplastic syndrome that has come back. Drugs used in chemotherapy, such as venetoc…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Engineered immune cells take on childhood cancer
Disease control Recruiting nowThis research study combines two different ways of fighting cancer: antibodies and Natural Killer T cells (NKT). Antibodies are types of proteins that protect the body from infectious diseases and possibly cancer. T cells, also called T lymphocytes, are special white blood cells …
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC
-
New procedure shows promise for treating pulmonary hypertension
Disease control CompletedThe objective of this randomized control trial is to gain clinical insight on the use of pulmonary artery denervation (PADN) for the treatment of pulmonary arterial hypertension (PAH). The primary objective is to assess effectiveness and safety of PADN for the treatment of PAH.
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Exercise as medicine? trial tests ways to boost activity in bipolar disorder
Symptom relief CompletedThe investigators propose a randomized clinical trial in which 24 individuals with bipolar disorder are assigned to one of three arms, with each successive arm having an added component that may serve to increase and maintain physical activity: 1. brief advice (BA) to exercise (…
Sponsor: Butler Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo aims to control rare blood cancer in High-Risk patients
Disease control Recruiting nowThis phase II trial studies the side effects and how well azacitidine and enasidenib work in treating patients with IDH2-mutant myelodysplastic syndrome. Azacitidine and enasidenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Immunotherapy after melanoma surgery shows promise in early trial
Disease control CompletedThis phase II trial studies how well nivolumab works in treating patients with stage IIB-IIC melanoma that can be removed by surgery. Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread.
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can adding surgery or radiation to a targeted pill slow lung cancer better?
Disease control OngoingThis phase II trial studies how well osimertinib, surgery, and radiation therapy work in treating patients with stage IIIB or IV non-small cell lung cancer with EGFR mutations. Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could an HIV drug boost cervical cancer treatment?
Disease control CompletedThe primary aim of the trial is to study the impact of nelfinavir on 3 year disease free survival in patients with advanced carcinoma of cervix receiving standard chemoradiation (Cisplatin and Radiotherapy). There will be two study groups. One group will receive standard treatme…
Phase 3 • Sponsor: Tata Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Immunotherapy combo shows promise in tough brain cancer trial
Disease control OngoingThis phase II trial studies the side effects and how well pembrolizumab works in combination with standard therapy in treating patients with glioblastoma. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could 4 months of chemo be enough for stomach cancer?
Disease control CompletedOur study aims to compare 4 months versus 6 months of adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in patients with gastric cancer. Hypothesis: We hypothesize that a 4-month regimen of capecitabine plus oxaliplatin is noninferior to a 6-month regimen with respect …
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Airbag for people: new wearable tech aims to soften falls
Disease control OngoingThe purpose of this study is to evaluate the feasibility and efficacy of a smart airbag system that detects and mitigates fall-related impact in individuals with high fall risk.
Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control CompletedThe study drug elotuzumab, has been clinically shown to be effective in treating relapsed/refractory MM in combination with either bortezomib, or lenalidomide and dexamethasone. Elotuzumab in combination with lenalidomide and dexamethasone is currently approved by the Food and Dr…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Gene therapy shows promise in Long-Term study for rare blindness
Disease control CompletedThe goal of this clinical trial is to assess the long-term safety and efficacy of GS010, a gene therapy, and assess the quality of life in subjects with LHON due to the G11778A ND4 mitochondrial mutation and who were treated in the Rescue or Reverse studies.
Phase 3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Blood transfusion thresholds tested to save elderly surgical patients
Disease control CompletedIn this prospective, multicentre, open, randomised, controlled clinical trial elderly patients (≥ 70 years) undergoing intermediate- or high-risk non-cardiac surgery will be randomised either to a liberal group (patients receive a RBC unit each time Hb falls ≤ 9 g/dl (≤ 5.6mmol/l…
Phase 3 • Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Heart bypass showdown: does using more arteries save lives?
Disease control Recruiting nowThe primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a single arterial graft is associated with a reduction in the composite outcome of death from any …
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Drug combo shows promise against rare brain tumor
Disease control OngoingThis phase II trial studies how well vemurafenib and cobimetinib work in treating patients with BRAF V600E mutation positive craniopharyngioma. Vemurafenib and cobimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Phase 2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a playlist be the new Pre-Surgery calm?
Symptom relief Recruiting nowThe use of music to relieve pain has been studied in many forms of medicines and has been proven to reduce anxiety, pain and analgesic use in the perioperative setting. However, music listening as an inexpensive and duplicable method has not been investigated and implemented in t…
Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Diet and exercise may boost chemotherapy completion in breast cancer patients
Disease control CompletedThe proposed study is a randomized trial evaluating the impact of a dietary and physical activity guidelines intervention vs. usual care on adherence to breast cancer treatments, body composition, and changes in biomarkers in 172 women newly diagnosed with breast cancer scheduled…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Breath test and antibiotics aim to slash stomach cancer in indigenous communities
Prevention Recruiting nowThe incidence of gastric cancer in local indigenous peoples is higher than the non-Indigenous counterpart in Taiwan. How to design an effective prevention strategy for gastric cancer is of importance. The present study aimed to identify the causes that may account for the health …
Sponsor: National Taiwan University Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC